124 related articles for article (PubMed ID: 10743925)
21. Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study.
Taber SW; Fingar VH; Coots CT; Wieman TJ
Clin Cancer Res; 1998 Nov; 4(11):2741-6. PubMed ID: 9829737
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces.
Chan AL; Juarez M; Allen R; Volz W; Albertson T
Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):72-8. PubMed ID: 15752124
[TBL] [Abstract][Full Text] [Related]
23. Selective occlusion of choroidal neovascularization by photodynamic therapy with a water-soluble photosensitizer, ATX-S10.
Obana A; Gohto Y; Kaneda K; Nakajima S; Takemura T; Miki T
Lasers Surg Med; 1999; 24(3):209-22. PubMed ID: 10229152
[TBL] [Abstract][Full Text] [Related]
24. Feasibility of laser-targeted photoocclusion of the choriocapillary layer in rats.
Asrani S; Zou S; D'Anna S; Lutty G; Vinores SA; Goldberg MF; Zeimer R
Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2702-10. PubMed ID: 9418722
[TBL] [Abstract][Full Text] [Related]
25. Lutetium texaphyrin (Lu-Tex): a potential new agent for ocular fundus angiography and photodynamic therapy.
Blumenkranz MS; Woodburn KW; Qing F; Verdooner S; Kessel D; Miller R
Am J Ophthalmol; 2000 Mar; 129(3):353-62. PubMed ID: 10704552
[TBL] [Abstract][Full Text] [Related]
26. Photodynamic therapy with mono-L-aspartyl chlorin e6 can cause necrosis of squamous cell carcinoma of tongue: experimental study on an animal model of nude mouse.
Kobayashi W; Liu Q; Nakagawa H; Sakaki H; Teh B; Matsumiya T; Yoshida H; Imaizumi T; Satoh K; Kimura H
Oral Oncol; 2006 Jan; 42(1):46-50. PubMed ID: 16266818
[TBL] [Abstract][Full Text] [Related]
27. Comparison of reduced and standard light application in photodynamic therapy of the eye in two rabbit models.
Framme C; Flucke B; Birngruber R
Graefes Arch Clin Exp Ophthalmol; 2006 Jul; 244(7):773-81. PubMed ID: 16440207
[TBL] [Abstract][Full Text] [Related]
28. Retreatment effect of NPe6 photodynamic therapy on the normal primate macula.
Nakashizuka T; Mori K; Hayashi N; Anzail K; Kanail K; Yoneya S; Moshfeghi DM; Peyman GA
Retina; 2001; 21(5):493-8. PubMed ID: 11642379
[TBL] [Abstract][Full Text] [Related]
29. [A basic study of photodynamic therapy of experimental hepatoma with ME 2906].
Nakamura J; Kajiwara H; Nakamura M; Watanabe M; Naganuma K; Tanaka H; Usui S; Sumiyama Y; Saito K; Aizawa K
Gan To Kagaku Ryoho; 1998 Jul; 25(9):1454-6. PubMed ID: 9703852
[TBL] [Abstract][Full Text] [Related]
30. Retinal injury thresholds for 532, 578, and 630 nm lasers in connection to photodynamic therapy for choroidal neovascularization.
Chen H; Yang Z; Zou X; Wang J; Zhu J; Gu Y
Lasers Surg Med; 2014 Jan; 46(1):54-60. PubMed ID: 24307505
[TBL] [Abstract][Full Text] [Related]
31. [Selective occlusion of subretinal neovascularization with photodynamic therapy].
Schmidt-Erfurth U; Hasan T; Gragoudas E; Birngruber R
Ophthalmologe; 1994 Dec; 91(6):789-95. PubMed ID: 7849433
[TBL] [Abstract][Full Text] [Related]
32. [Photodynamic therapy of pigmented choroidal melanomas in rabbits using hematoporphyrin monomethyl ether].
Ji HX; Zhang F; Gao LQ; Jia LY; Xiong Y; Liang C; Li LQ
Zhonghua Yan Ke Za Zhi; 2007 Mar; 43(3):212-6. PubMed ID: 17605902
[TBL] [Abstract][Full Text] [Related]
33. Metabolic properties and photosensitizing responsiveness of mono-L-aspartyl chlorin e6 in a mouse tumor model.
Ferrario A; Kessel D; Gomer CJ
Cancer Res; 1992 May; 52(10):2890-3. PubMed ID: 1581904
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of photopoint photosensitizer mv6401, indium chloride methyl pyropheophorbide, as a photodynamic therapy agent in primate choriocapillaris and laser-induced choroidal neovascularization.
Ciulla TA; Criswell MH; Danis RP; Snyder WJ; Small W
Retina; 2004 Aug; 24(4):521-9. PubMed ID: 15300072
[TBL] [Abstract][Full Text] [Related]
35. [Effect of photodynamic therapy with ATX-S 10 (Na) on experimental choroidal neovascularization].
Hirose T; Nakajima M; Kyou T; Yuzawa M
Nippon Ganka Gakkai Zasshi; 2006 Jun; 110(6):445-53. PubMed ID: 16808159
[TBL] [Abstract][Full Text] [Related]
36. Choriocapillaris photodynamic therapy using indocyanine green.
Costa RA; Farah ME; Freymüller E; Morales PH; Smith R; Cardillo JA
Am J Ophthalmol; 2001 Oct; 132(4):557-65. PubMed ID: 11589879
[TBL] [Abstract][Full Text] [Related]
37. Photodynamic therapy of pigmented choroidal melanomas using a liposomal preparation of benzoporphyrin derivative.
Young LH; Howard MA; Hu LK; Kim RY; Gragoudas ES
Arch Ophthalmol; 1996 Feb; 114(2):186-92. PubMed ID: 8573023
[TBL] [Abstract][Full Text] [Related]
38. A new Chlorin formulation promotes efficient photodynamic action in choriocapillaris of rabbit's eyes.
Salomao GHA; Fernandes AU; Baptista MS; Tardivo JP; Gianssante S; Veridiano JM; Toledo OMS; Petri G; Christofolini DM; Correa JA
Bioorg Med Chem Lett; 2018 Jun; 28(10):1870-1873. PubMed ID: 29661534
[TBL] [Abstract][Full Text] [Related]
39. Photodynamic therapy for corneal neovascularization.
Primbs GB; Casey R; Wamser K; Snyder WJ; Crean DH
Ophthalmic Surg Lasers; 1998 Oct; 29(10):832-8. PubMed ID: 9793949
[TBL] [Abstract][Full Text] [Related]
40. Threshold parameters for choroidal vessel closure with the photosensitizer, lambda 27.
Genaidy M; Kazi AA; Peyman GA; Farahat H; Kivilcim M; Laghari NA; Afzal S
J Coll Physicians Surg Pak; 2007 Apr; 17(4):215-8. PubMed ID: 17462179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
